Scientists at Healzen Therapeutics Co. Ltd. and Shanghai Institute of Materia Medica of the Chinese Academy of Sciences have described GTPase KRAS (G12D mutant) inhibitors reported to be useful for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback